2001
DOI: 10.1118/1.1359246
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of I‐125 sources used for permanent interstitial implants

Abstract: The increase in the number of manufacturers of 125I sources used in prostate brachytherapy has generated many questions in the radiation oncology community. In this investigation, the physical and dosimetric characteristics were evaluated for the following sources listed by marketing company and source model: Nycomed-Amersham 6711 (OncoSeed), Nycomed-Amersham 6702, Mentor IoGold, UroMed Symmetra, Imagyn IsoSTAR, UroCor, (PSA, Mallincrkrodt) ProstaSeed, Syncor PharmaSeed, SourceTech Medical, (BARD) 125Implant (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
42
0
12

Year Published

2002
2002
2020
2020

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(55 citation statements)
references
References 27 publications
(64 reference statements)
1
42
0
12
Order By: Relevance
“…Therefore, characteristic radiation photons can not travel far before they are absorbed and they are usually ignored in the dosimetry calculations and we also adopted this approach. [61] The typical mesh size we used in our calculations is 0.25cm x 0.25cm x 0.25cm. 40 x 40 x 40 meshes are needed to a cover 10cm x 10cm x 10cm volume.…”
Section: Volumetric Source Results -Model 2301mentioning
confidence: 99%
“…Therefore, characteristic radiation photons can not travel far before they are absorbed and they are usually ignored in the dosimetry calculations and we also adopted this approach. [61] The typical mesh size we used in our calculations is 0.25cm x 0.25cm x 0.25cm. 40 x 40 x 40 meshes are needed to a cover 10cm x 10cm x 10cm volume.…”
Section: Volumetric Source Results -Model 2301mentioning
confidence: 99%
“…The dose to the sensitive organs should not exceed their tolerance levels [7]. In various studies, 125 I, 103 Pd, 169 Yb, and 192 Ir brachytherapy sources were evaluated in prostate brachytherapy [2,4,8,9]. It should be noted that in addition to 125 I and 103 Pd brachytherapy sources, there are also high-dose-rate (HDR) radionuclides ( 192 Ir) that are routinely used in prostate brachytherapy.…”
Section: Purposementioning
confidence: 99%
“…• UroMed Corporation -Bebig GmbH (Alemanha) Symmetra I-125.S06: Cápsula de titânio selada a laser, contendo no seu interior fio de ouro radio-opaco, e uma camada de cerâmica com iodo-125 (30) ;…”
Section: Sementes De Iodo-125 Encontradas No Mercadounclassified
“…• GE -Amersham (EUA) OncoSeed 6711: Núcleo de prata radio-opaco, onde o iodo-125 está adsorvido e a cápsula externa é de titânio, com selagem a laser (30) ;…”
Section: Sementes De Iodo-125 Encontradas No Mercadounclassified
See 1 more Smart Citation